tldrdaily.news logo

Inhaled Heparin and Low-Cost Drugs Show Promise in Treating Severe COVID-19

1 min read
Source: CIDRAP
Inhaled Heparin and Low-Cost Drugs Show Promise in Treating Severe COVID-19
Photo: CIDRAP
TL;DR Summary

A meta-trial across six countries found that inhaled heparin significantly reduces the risk of intubation and death in hospitalized COVID-19 patients, likely due to its antiviral, anti-inflammatory, and anti-coagulant properties, suggesting potential broader applications for respiratory diseases.

Topics:health#covid-19#health#heparin#inhaled-therapy#lung-injury#mortality-reduction
Share this article
  1. Inhaled heparin slashes ventilation, death in COVID patients, analysis suggests  CIDRAP
  2. Doctors tested a common drug on COVID. The results are stunning  ScienceDaily
  3. Low-cost drug shows promise for patients with life threating respiratory infections  King's College London

Reading Insights

Total Reads

0

Unique Readers

3

Time Saved

2 min

vs 3 min read

Condensed

91%

416 → 37 words

Want the full story? Read the original article

Read on CIDRAP